FDA Regulation of Implantable Sensors: Demonstrating Safety and Effectiveness for Marketing in the U.S

Implantable sensors are gaining considerable attention in the research and medical communities due to their potential to enhance the detection and monitoring of medical conditions such as cancer, diabetes, and heart disease. The use of implantable sensors for these exciting applications bring them u...

Full description

Saved in:
Bibliographic Details
Published in:IEEE sensors journal 2008-01, Vol.8 (1), p.52-56
Main Authors: Smith, J.J., Henderson, J.A.
Format: Article
Language:English
Subjects:
Biomedical monitoring
Biosensors
Cancer detection
Cardiac disease
Condition monitoring
Diabetes
Drugs
Food and Drug Administration (FDA)
implantable sensors
In vivo
Medical conditions
medical device regulation
Safety
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Implantable sensors are gaining considerable attention in the research and medical communities due to their potential to enhance the detection and monitoring of medical conditions such as cancer, diabetes, and heart disease. The use of implantable sensors for these exciting applications bring them under the regulatory oversight of the United States Food and Drug Administration (FDA). As medical devices intended for long-term implantation that inherently involve some risk, the FDA will carefully evaluate these products prior to allowing them to enter the U.S. market. This paper provides a brief overview of the FDA medical device regulatory framework under which implantable sensors for medical purposes are regulated. It also addresses particular concerns the FDA may raise with respect to these products including, potential sensor breakage and migration in vivo , biocompatibility, electromagnetic compatibility, electromagnetic interference, wireless telemetry, risk/benefit, and clinical utility.
ISSN:1530-437X
1558-1748
DOI:10.1109/JSEN.2007.912548